Company · CIK 0000899923 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq
MYRIAD GENETICS INC · MYGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2015 SForm 4 → | Sep 17, 6:32 pm EDT | Richard M MarshE.V.P., General Counsel | 35,000 | $41.25 | $1,443,750 | 74,227 | −32.0% | plan? |
| Sep 16, 2015 FMForm 4 → | Sep 17, 6:32 pm EDT | Richard M MarshE.V.P., General Counsel | 41,684 | $25.89 | $1,079,201 | 67,543 | — | plan? |
| Sep 15, 2015 AFForm 4 → | Sep 22, 6:58 pm EDT | Ralph L McDadePresident Myriad RBM, Inc. | 26,188 | $41.39 | $90,561 | 55,157 | — | plan? late |
| Sep 15, 2015 AFForm 4 → | Sep 17, 6:47 pm EDT | Gary A. KingExec. VP International Ops | 39,900 | $41.39 | $223,506 | 80,573 | — | plan? |
| Sep 15, 2015 AFForm 4 → | Sep 17, 6:41 pm EDT | Richard WenstrupChief Medical Officer | 12,431 | $41.39 | $38,534 | 22,069 | — | plan? |
| Sep 15, 2015 SForm 4 → | Sep 17, 6:40 pm EDT | Jerry S LanchburyChief Scientific Officer | 60,270 | $39.89 | $2,403,921 | 70,737 | −46.0% | plan? |
| Sep 15, 2015 FMForm 4 → | Sep 17, 6:40 pm EDT | Jerry S LanchburyChief Scientific Officer | 67,167 | $19.31 | $1,297,030 | 71,007 | — | plan? |
| Sep 15, 2015 AFForm 4 → | Sep 17, 6:26 pm EDT | Alexander FordPresident, MGL | 18,437 | $41.39 | $80,172 | 34,094 | — | plan? |
| Sep 14, 2015 SForm 4 → | Sep 16, 4:34 pm EDT | Gary A. KingExec. VP International Ops | 14,562 | $39.41 | $573,888 | 51,473 | −22.1% | plan? |
| Sep 14, 2015 MForm 4 → | Sep 16, 4:34 pm EDT | Gary A. KingExec. VP International Ops | 14,562 | $19.47 | $283,522 | 66,035 | — | plan? |
| Sep 3, 2015 SForm 4 → | Sep 8, 4:08 pm EDT | Gary A. KingExec. VP International Ops | 25,438 | $39.41 | $1,002,512 | 51,473 | −33.1% | plan? |
| Sep 3, 2015 MForm 4 → | Sep 8, 4:08 pm EDT | Gary A. KingExec. VP International Ops | 25,438 | $19.47 | $495,278 | 76,911 | — | plan? |
| Sep 2, 2015 GMForm 4 → | Oct 7, 4:56 pm EDT | Richard M MarshE.V.P., General Counsel | 7,208 | $30.25 | $187,821 | 72,751 | — | plan? late |
| Sep 2, 2015 SForm 4 → | Sep 2, 4:24 pm EDT | Gary A. KingExec. VP International Ops | 15,000 | $38.23 | $573,450 | 51,473 | −22.6% | plan? |
| Sep 2, 2015 MForm 4 → | Sep 2, 4:24 pm EDT | Gary A. KingExec. VP International Ops | 15,000 | $18.00 | $270,000 | 66,473 | — | plan? |
| Aug 28, 2015 SForm 4 → | Aug 31, 4:14 pm EDT | Gary A. KingExec. VP International Ops | 30,000 | $35.73 | $1,071,900 | 51,473 | −36.8% | plan? |
| Aug 28, 2015 MForm 4 → | Aug 31, 4:14 pm EDT | Gary A. KingExec. VP International Ops | 30,000 | $14.88 | $446,400 | 81,473 | — | plan? |
| Aug 13, 2015 AForm 4 → | Aug 14, 4:44 pm EDT | Jerry S LanchburyChief Scientific Officer | 58,754 | — | — | 77,634 | — | plan? |
| Aug 13, 2015 AForm 4 → | Aug 14, 4:41 pm EDT | Richard M MarshE.V.P., General Counsel | 56,946 | — | — | 74,227 | — | plan? |
| Aug 13, 2015 AForm 4 → | Aug 14, 4:38 pm EDT | Mark Christopher CaponePresident & C.E.O. | 99,429 | — | — | 147,697 | — | plan? |
| Jan 2, 2015 AFForm 4 → | Jan 6, 2:12 pm EST | Bernard TobinPresident Crescendo BioScience | 44,720 | $34.61 | $163,359 | 35,280 | — | plan? |
| Dec 22, 2014 GMForm 4 → | Mar 3, 2015, 5:24 pm EST | Richard M MarshE.V.P., General Counsel | 10,879 | $18.00 | $99,990 | 16,778 | — | plan? late |
| Nov 3, 2014 GMForm 4 → | May 8, 2015, 4:17 pm EDT | Peter D MeldrumPresident & C.E.O., Director | 11,555 | $18.00 | $99,990 | 10,424 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2018 MForm 4 → | Jul 13, 4:25 pm EDT | Jerry S LanchburyChief Scientific Officer | 50,000 | — | — | 0 | — | |
| Jul 11, 2018 MForm 4 → | Jul 13, 4:23 pm EDT | John T HendersonDirector | 30,000 | — | — | 0 | — | |
| Jul 11, 2018 MForm 4 → | Jul 13, 4:19 pm EDT | Richard M MarshE.V.P., General Counsel | 70,672 | — | — | 0 | — | |
| Jul 11, 2018 MForm 4 → | Jul 13, 4:16 pm EDT | Mark Christopher CaponePresident & C.E.O. | 80,000 | — | — | 0 | — | |
| Jun 18, 2018 MForm 4 → | Jun 19, 4:49 pm EDT | Jerry S LanchburyChief Scientific Officer | 60,000 | — | — | 0 | — | |
| Jun 18, 2018 MForm 4 → | Jun 19, 4:46 pm EDT | Richard M MarshE.V.P., General Counsel | 33,000 | — | — | 0 | — | |
| Jun 6, 2018 MForm 4 → | Jun 8, 5:37 pm EDT | Dennis LangerDirector | 20,369 | — | — | 0 | — | |
| Jun 5, 2018 MForm 4 → | Jun 7, 4:00 pm EDT | Walter Gilbert Ph.D.Director | 30,000 | — | — | 0 | — | |
| Jun 1, 2018 MForm 4 → | Jun 5, 5:45 pm EDT | Dennis LangerDirector | 49,631 | — | — | 0 | — | |
| May 30, 2018 MForm 4 → | Jun 1, 5:43 pm EDT | Mark Christopher CaponePresident & C.E.O. | 90,000 | — | — | 0 | — | |
| May 30, 2018 MForm 4 → | Jun 1, 4:43 pm EDT | Richard M MarshE.V.P., General Counsel | 33,139 | — | — | 33,000 | — | |
| May 30, 2018 MForm 4 → | Jun 1, 4:37 pm EDT | Dennis LangerDirector | 10,000 | — | — | 10,000 | — | |
| May 21, 2018 MForm 4 → | May 21, 7:54 pm EDT | Dennis LangerDirector | 10,000 | $35.90 | $359,000 | 20,000 | — | |
| Jan 22, 2018 MForm 4 → | Jan 22, 6:16 pm EST | Gary A. KingExec. VP International Ops | 34,445 | — | — | 27,432 | — | |
| Jan 22, 2018 MForm 4 → | Jan 22, 6:12 pm EST | Richard M MarshE.V.P., General Counsel | 41,429 | — | — | 0 | — | |
| Jan 18, 2018 MForm 4 → | Jan 19, 2:26 pm EST | Richard M MarshE.V.P., General Counsel | 40,000 | — | — | 37,654 | — | |
| Jan 18, 2018 MForm 4 → | Jan 19, 2:21 pm EST | Gary A. KingExec. VP International Ops | 3,120 | — | — | 0 | — | |
| Sep 1, 2017 MForm 4 → | Sep 5, 2:08 pm EDT | John T HendersonDirector | 30,000 | — | — | 0 | — | |
| Sep 9, 2016 MForm 4 → | Sep 13, 10:38 am EDT | John T HendersonDirector | 30,000 | — | — | 0 | — | |
| Jun 21, 2016 MForm 4 → | Jun 22, 5:05 pm EDT | Alexander FordPresident, MGL | 16,449 | — | — | 0 | — | |
| Jun 16, 2016 MForm 4 → | Jun 16, 5:10 pm EDT | Richard M MarshE.V.P., General Counsel | 4,170 | — | — | 0 | — | |
| Apr 6, 2016 MForm 4 → | Apr 8, 6:27 pm EDT | Gary A. KingExec. VP International Ops | 15,000 | — | — | 4,445 | — | |
| Apr 1, 2016 MForm 4 → | Apr 5, 10:24 am EDT | Gary A. KingExec. VP International Ops | 15,000 | — | — | 3,120 | — | |
| Nov 5, 2015 MForm 4 → | Nov 5, 6:14 pm EST | Heinrich DreismannDirector | 60,000 | — | — | 0 | — | |
| Nov 4, 2015 MForm 4 → | Nov 5, 4:26 pm EST | Richard M MarshE.V.P., General Counsel | 35,000 | — | — | 0 | — | |
| Oct 28, 2015 MForm 4 → | Oct 28, 6:34 pm EDT | Gary A. KingExec. VP International Ops | 10,000 | — | — | 11,830 | — | |
| Oct 28, 2015 MForm 4 → | Oct 28, 4:16 pm EDT | Jerry S LanchburyChief Scientific Officer | 50,962 | — | — | 0 | — | |
| Oct 23, 2015 MForm 4 → | Oct 27, 5:01 pm EDT | Jerry S LanchburyChief Scientific Officer | 24,767 | — | — | 50,962 | — | |
| Oct 6, 2015 MForm 4 → | Oct 7, 4:56 pm EDT | Richard M MarshE.V.P., General Counsel | 6,208 | — | — | 0 | — | |
| Sep 16, 2015 MForm 4 → | Sep 17, 6:32 pm EDT | Richard M MarshE.V.P., General Counsel | 35,000 | — | — | 35,000 | — | |
| Sep 15, 2015 MForm 4 → | Sep 17, 6:40 pm EDT | Jerry S LanchburyChief Scientific Officer | 60,270 | — | — | 0 | — | |
| Sep 14, 2015 MForm 4 → | Sep 16, 4:34 pm EDT | Gary A. KingExec. VP International Ops | 14,562 | — | — | 57,432 | — | |
| Sep 3, 2015 MForm 4 → | Sep 8, 4:08 pm EDT | Gary A. KingExec. VP International Ops | 25,438 | — | — | 71,994 | — | |
| Sep 2, 2015 MForm 4 → | Sep 2, 4:24 pm EDT | Gary A. KingExec. VP International Ops | 15,000 | — | — | 19,445 | — | |
| Aug 28, 2015 MForm 4 → | Aug 31, 4:14 pm EDT | Gary A. KingExec. VP International Ops | 30,000 | — | — | 18,120 | — | |
| May 6, 2015 MForm 4 → | May 8, 4:17 pm EDT | Peter D MeldrumPresident & C.E.O., Director | 5,555 | — | — | 0 | — | |
| Mar 2, 2015 MForm 4 → | Mar 3, 5:24 pm EST | Richard M MarshE.V.P., General Counsel | 5,555 | — | — | 0 | — |